Patents by Inventor John Talley

John Talley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11126853
    Abstract: A method and system can generate video content from a video. The method and system can include a coordinator, an image detector, and an object recognizer. The coordinator can be communicatively coupled to a splitter and/or to a plurality of demultiplexer nodes. The splitter can be configured to segment the video. The demultiplexer nodes can be configured to extract audio files from the video and/or to extract still frame images from the video. The image detector can be configured to detect images of objects in the still frame images. The object recognizer can be configured to compare an image of an object to a fractal. The recognizer can be further configured to update the fractal with the image. The coordinator can be configured to embed metadata about the object into the video.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: September 21, 2021
    Assignee: CELLULAR SOUTH, INC.
    Inventors: Bartlett Wade Smith, IV, Allison A. Talley, John Carlos Shields
  • Publication number: 20210274754
    Abstract: An attachment for a wearable collar of an animal may be provided. The attachment may include an electronic device comprising a processor configured to receive or transmit information relating to the animal. An attachment body may be configured to be detachably coupled to the collar worn by the animal. The attachment body may include a cavity housing the electronic device and an opening of the cavity. The opening may provide access to the electronic device housed in the cavity or retaining the electronic device within the cavity via an enclosure element. Each of a plurality of legs may have a connection element. The connection element may be configured to engage with another connection element to detachably couple the attachment body to the collar worn by the animal.
    Type: Application
    Filed: May 14, 2020
    Publication date: September 9, 2021
    Applicant: Hill's Pet Nutrition, Inc.
    Inventors: Ryan TALLEY, Susan WERNIMONT, Cheryl STIERS, Gerrit WASLANDER, Jodi VONDRAN, John Michael MCCOY, JR., Stephen John FRENCH
  • Publication number: 20210274750
    Abstract: A wearable animal information apparatus may be provided that includes a collar configured to be worn around a portion of an animal. The collar may include an inner surface that faces the portion of the animal during use and an outer surface that faces away from the portion of the animal during use. The animal information apparatus may include a base coupled to the collar and a housing configured to couple to the base via an attachment element. The housing may include a plurality of indicators providing visual information relating to at least one of a condition of the animal or an environment surrounding the animal. An electronic device, located within the housing, may include a processor configured to receive or transmit information relating to the animal. The base may include a cavity for receiving the housing and coupling the base to the housing via the attachment element.
    Type: Application
    Filed: May 14, 2020
    Publication date: September 9, 2021
    Applicant: Hill's Pet Nutrition, Inc.
    Inventors: Susan WERNIMONT, Jodi VONDRAN, Ryan TALLEY, John Michael MCCOY, JR., Stephen John FRENCH, Cheryl STIERS, Gerrit WASLANDER
  • Publication number: 20210274749
    Abstract: A monitoring device may be provided that couples to a wearable collar for an animal. A housing may include a cavity with an open top end and a cover movable between a first position wherein the cover closes the open top end of the cavity and a second position wherein the open top end of the cavity is exposed. An electronic device may be positioned within the cavity, the electronic device including a processor configured to receive or transmit information relating to the animal wearing the wearable collar. A first connection portion may be coupled to the housing and configured to attach to a first member of a first terminating end of the wearable collar. A second connection portion may be coupled to the housing and configured to attach to a second member of a second terminating end of the wearable collar.
    Type: Application
    Filed: May 14, 2020
    Publication date: September 9, 2021
    Applicant: Hill's Pet Nutrition, Inc.
    Inventors: Susan WERNIMONT, Jodi VONDRAN, Ryan TALLEY, John Michael MCCOY, JR., Stephen John FRENCH, Cheryl STIERS, Gerrit WASLANDER
  • Publication number: 20210262227
    Abstract: A stripping lifting insert is provided for precast insulated panels having an insulating material layer between opposing wythes, the insulating material layer, wythes, and precast insulated panel having respective widths. The stripping lifting insert includes an elongated connecting shaft having a shaft axis. First and second spaced apart wythe engagement members are connected to the connecting shaft in spaced apart relation to each other. Each wythe engagement member includes a hub and a plurality of three or more protrusions connected to and emanating from hub. Each of the protrusions extending radially outward from the shaft axis. The wythe engagement members have a height less than the width of the wythes, whereby each wythe engagement member can be completely embedded in a respective wythe of the precast insulated panel. A precast insulated panel and a method of making a precast insulated panel are also disclosed.
    Type: Application
    Filed: February 26, 2021
    Publication date: August 26, 2021
    Inventors: DIANA HUN, UDAY K. VAIDYA, STEPHEN W. SHERIFF, DYLAN M. TALLEY, NOLAN W. HAYES, ZHONGGUO JOHN MA
  • Publication number: 20090186834
    Abstract: Various azetidinone, pyrrolidine, imidazolidine, and oxazolidine derivatives are described, as are pharmaceutical compositions containing these compounds and methods of treatment of diseases using these compounds. Other embodiments are also described.
    Type: Application
    Filed: March 24, 2006
    Publication date: July 23, 2009
    Applicant: MICROBIA, INC.
    Inventors: John Talley, Eduardo Martinez, Daniel Zimmer, Regina Lundrigan
  • Publication number: 20070293542
    Abstract: The invention features compounds that are inhibitors of COX-2 activity. Certain of the compounds are inhibitors of FAAH activity as well as COX-2 activity. The compounds include a 5-membered or 6-membered substituted or unsubstituted heteroaryl or heterocyclyl ring having one or two heteroatoms selected from the group consisting of O, S, and N that is linked to two substituted or unsubstituted 6-membered aryl or heteroaryl groups that can be the same or different.
    Type: Application
    Filed: October 18, 2004
    Publication date: December 20, 2007
    Inventors: Brian Cali, Yueh-Tyng Chien, Mark Currie, John Talley, Craig Zimmerman
  • Publication number: 20070249644
    Abstract: Compounds and methods for the treatment of asthma are disclosed. The methods involve mast cell stabilization together with selective inhibition of iNOS. The compounds are combinations of a mast cell inhibiting moiety and an inhibitor of iNOS.
    Type: Application
    Filed: December 23, 2004
    Publication date: October 25, 2007
    Applicant: MICROBIA, INC.
    Inventors: James Pearson, John Talley, Mark Currie
  • Publication number: 20070203209
    Abstract: Indoles having various activities, including indoles that are CRTH2 are described. The compounds are useful for treating asthma, neuropathic pain, allegic rhinitis and other disorders.
    Type: Application
    Filed: August 18, 2006
    Publication date: August 30, 2007
    Inventors: Wilmin Bartolini, Brian Cali, Barbara Chen, Yueh-Tyng Chien, Mark Currie, G. Milne, James Pearson, John Talley, Jing Yang, Craig Zimmerman, Alex Monreal
  • Patent number: 7259266
    Abstract: The subject invention concerns methods and compounds that have utility in the treatment of a condition associated with cyclooxygenase-2 mediated disorders. Compounds of particular interest are benzopyrans and their analogs defined by formula 1 Wherein Z, X, R1, R2, R3, and R4 are as described in the specification.
    Type: Grant
    Filed: March 16, 2004
    Date of Patent: August 21, 2007
    Assignee: Pharmacia Corporation
    Inventors: Jeffry Carter, David Brown, Li Xing, Karl Aston, John Springer, Francis Koszyk, Steven Kramer, Renee Huff, Yi Yu, Bruce Hamper, Subo Laio, Angela Deprow, Teresa Fletcher, E. Ann Hallinan, James Kiefer, David Limburg, Lijuan Wang, Cindy Ludwig, John McCall, John Talley
  • Publication number: 20070161577
    Abstract: Derivatives of 1,4-diphenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed.
    Type: Application
    Filed: August 27, 2004
    Publication date: July 12, 2007
    Inventors: Eduardo Martinez, John Talley
  • Publication number: 20070161698
    Abstract: Modulators of the CRTH2 receptor and their use in the treatment of various disorders, including asthma are described.
    Type: Application
    Filed: March 13, 2007
    Publication date: July 12, 2007
    Inventors: Yueh-Tyng Chien, G. Milne, Mark Currie, John Talley, Brian Cali, Barbara Chen, Craig Zimmerman, Jing Yang
  • Publication number: 20070078146
    Abstract: A class of pyrazole derivatives is described for use in treating p38 kinase medicated disorders. Compounds of particular interest are defined by Formula IA wherein R1, R2, R3 and R4 are as described in the specification.
    Type: Application
    Filed: May 5, 2004
    Publication date: April 5, 2007
    Inventors: Ashok Naraian, Michael Clare, Paul Collins, Joyce Crich, Rajesh Devraj, Daniel Flynn, Lifeng Geng, Matthew Graneto, Cathleen Hanau, Gunnar Hanson, Susan Hartmann, Michael Hepperle, He Huang, Ish Khanna, Francis Koszyk, Shuyuan Liao, Suzanne Metz, Win Naing, Richard Partis, Thao Perry, Shashidhar Rao, Shaun Selness, Michael South, Michael Stealey, John Talley, Michael Vazquez, John Walker, Richard Weier, Xiangdong Xu, Syaulan Yang, Yi Yu
  • Publication number: 20070078173
    Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
    Type: Application
    Filed: September 25, 2006
    Publication date: April 5, 2007
    Applicant: G.D. Searle & Co.
    Inventors: Michael Vazquez, Richard Mueller, John Talley, Daniel Getman, Gary DeCrescenzo, John Freskos, Robert Heintz, Deborah Bertenshaw
  • Publication number: 20070072812
    Abstract: Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones useful for the treatment of hypercholesterolemia are disclosed. The compounds are of the general formulae as well as isomers of these formulae.
    Type: Application
    Filed: August 25, 2004
    Publication date: March 29, 2007
    Applicant: Microbia, Inc.
    Inventors: Eduardo Martinez, John Talley
  • Publication number: 20070072921
    Abstract: A stable crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide is described. This crystal structure, designated Form B, is more stable, has favorable handling properties and is characterized by its melting point, x-ray and other physical characterizations.
    Type: Application
    Filed: November 6, 2006
    Publication date: March 29, 2007
    Inventors: John Talley, John Medich, Kathleen McLaughlin, Henry Gaud, Edward Yonan
  • Publication number: 20070015818
    Abstract: The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
    Type: Application
    Filed: July 5, 2006
    Publication date: January 18, 2007
    Applicants: G.D. Searle & Co. (now G.D. Searle, LLC), Monsanto Company (now Pharmacia Corporation)
    Inventors: Deborah Bertenshaw, Daniel Getman, Robert Heintz, John Talley, Kathryn Reed, Robert Chrusciel, Michael Clare
  • Publication number: 20060276493
    Abstract: ?- and ?-amino acid hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as-inhibitors of HIV protease.
    Type: Application
    Filed: May 15, 2006
    Publication date: December 7, 2006
    Applicant: G.D Searle & Co.
    Inventors: Michael Vasquez, Richard Mueller, John Talley, Daniel Getman, Gary DeCrescenzo, John Freskos, Deborah Bertenshaw, Robert Heintz
  • Publication number: 20060199822
    Abstract: Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease inhibiting compounds of the formula: or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein the variables are as defined herein.
    Type: Application
    Filed: February 8, 2006
    Publication date: September 7, 2006
    Applicant: G.D. Searle & Co.
    Inventors: John Freskos, Daniel Getman, John Talley, James Sikorski
  • Publication number: 20060167075
    Abstract: Methods for inhibiting the activity of FAAH and methods for preventing and/or treating certain disorders, e.g., anxiety disorders, sleep disorders and weight disorders, by administering celecoxib, valdecoxib or certain structurally related compounds at a dosage that is sufficient to treat and/or prevent the disorder are described.
    Type: Application
    Filed: January 25, 2006
    Publication date: July 27, 2006
    Inventors: James Pearson, G. Milne, Mark Currie, Brian Cali, John Talley